Table 1.

Clinical characteristics in the study groups. Cell count is n/μl CSF (reference range < 4 /μl). Albumin is mg/l (reference range < 400 mg/l)

Patient no.	Disease phase	CSF cell count		CSF Albumin
		Polynuclear	Mononuclear
1	Acute phase	31	43	560
	After treatment	0	2	259
2	Acute phase	445	80	3132
	After treatment	0	15	215
3	Acute phase	364	80	2546
	After treatment	2	37	143
4	Acute phase	310	12	665
	After treatment	46	4	211
5	Acute phase	9000	900	1650
	After treatment	missing	missing	1710
6	Acute phase	3400	744	missing
	After treatment	17	60	361